fda warning letters compounded semaglutide tirzepatide september 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA Targets GLP-1 and Peptide

Last month, the TGA delved into the Database of Adverse Event Notification to track incidents linked to GLP-1 and dual GIP/GLP-1 receptor agonists uncovering 11 reported adverse events

Open the pre-filled injection pen When you take the injection out of the refrigerator, make sure that the padlock symbol next to the purple button shows locked. Moreover, check the expiration date, and dose on the pen, and ensure that the pen is clear

WeightWatchers helps members navigate insurance and understand their options, which can make a big difference in affordability

The A-NPs@(SHK+Ce6) nanosystem incorporates CaCO3 nanoparticles to buffer excess H+ ions and alleviate suppressive conditions, while the loaded SHK peptide inhibits lactate production and synergizes with photodynamic therapy to repolarize TAMs toward the M1 phenotype (53)

Current Psychiatry Reports, 26(2), 43-55